-
StreetSweeper Short Bio-Path: 'Unfortunate' Analyst Support, Little Executive Biotech Experience
Tuesday, April 26, 2016 - 2:16pm | 593The Street Sweeper's Sonya Colberg published a scathing short thesis on Bio-Path Holdings Inc (NASDAQ: BPTH), a clinical-stage biotechnology company that focuses on developing drugs to fight cancer. Colberg's main criticism of the company is the fact that it "spent six years...